1. FOXO3a in cancer drug resistance
   Ying Liu et al, 2022, Cancer Letters CrossRef
2. Glycolysis in human cancers: Emphasis circRNA/glycolysis axis and nanoparticles in glycolysis regulation in cancer therapy
   Ali G. Alkhathami et al, 2023, Environmental Research CrossRef
3. Advances in the Study of CircRNAs in Tumor Drug Resistance
   Song Wang et al, 2022, Frontiers in Oncology CrossRef
4. The Role of Circular RNAs in the Drug Resistance of Cancers
   Xin-Yuan Liu et al, 2022, Frontiers in Oncology CrossRef
5. CircSETDB1 contributes to paclitaxel resistance of ovarian cancer cells by sponging miR-508-3p and regulating ABCC1 expression
   Chunyan Huang et al, 2023, Anti-Cancer Drugs CrossRef
6. LINC01082 Inhibits Non-Small Cell Lung Cancer by Targeting the miR-543/TNRC6A Axis
   Ran Yang et al, 2023, Biochemical Genetics CrossRef
7. Emerging role of competing endogenous RNA in lung cancer drug resistance
   Shijie Wu et al, 2023, Journal of Chemotherapy CrossRef
8. Molecular profile of non-coding RNA-mediated glycolysis control in human cancers
   Sepideh Mirzaei et al, 2023, Pathology - Research and Practice CrossRef
9. The role of selected non-coding RNAs in the biology of non-small cell lung cancer
   Kajetan Kiełbowski et al, 2023, Advances in Medical Sciences CrossRef
10. Knockdown of circEXOC6 inhibits cell progression and glycolysis by sponging miR-433-3p and mediating FZD6 in glioma
    Yu Deng et al, 2023, Translational Neuroscience CrossRef
11. Potential therapeutic strategy for cancer: Multi-dimensional cross-talk between circRNAs and parental genes
    Xiaoyu Sun et al, 2024, Cancer Letters CrossRef
12. Role of circ-FOXO3 and miR-23a in radiosensitivity of breast cancer
    Elahe Abdollahi et al, 2023, Breast Cancer CrossRef